Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
75 Cards in this Set
- Front
- Back
how does atropine work?
|
interrupts normal cholinergic, muscarinic transmission at the various end organs
|
|
Symptoms of Atropine overdose
|
Mad as a hatter-delirium
Blind as a bat-mydriasis Dry as a bone-dry mouth Red as a beet-Flushing Hot as a pistol- >body temp- |
|
A muscarinic agonists that competes with atropine and reverses its effect
|
pilocarpine
|
|
These two compounds combine to make acetylcholine
|
acetyl-Coenzyme A + choline
|
|
where are nicotinic receptors found?
|
neuromuscular junction of skeletal muscle
within ganglia and the CNS |
|
where are muscarinic receptors found?
|
within both peripheral and central nervous systems
|
|
After ACH is hydrolyzed what re-enters the motor nerve endings to again participate in the synthesis of new acetylcholine
|
Choline
|
|
this prevents sustained depolarization
|
Rapid hydrolysis of ACH
|
|
what can cause up-regulation of Nicotinic Acetylcholine Receptors (nAChR)
|
Spinal Cord Injury, CVA, Prolonged exposure to NMB drugs, Guillain-Barre syndrome
|
|
what can cause down-regulation of Nicotinic Acetylcholine Receptors
|
Down-regulation
Myasthenia Gravis Organophosphate Poisonings |
|
the only NMB drug that affects depolarization
|
SCh
|
|
At what dose is SCh ED 90-95
|
ED 90-95 @ 0.3 (mg/kg)
never go higher than this dose |
|
What is SCh used for?
|
Induction of neuromuscular blockade
During surgery as an adjunct to general anesthesia and to facilitate tracheal intubation or mechanical ventilation |
|
Dosing of SCh for short procedures
|
0.6 mg/kg IV (range 0.3-1.1 mg/kg) over 10-30 seconds
|
|
Dosing of SCh for long procedures
|
Initial loading dose of 0.3-1.1 mg/kg IV
followed by 0.04-0.07 mg/kg at appropriate intervals |
|
what is rapid sequence intubation
|
2 or 3 consecutive doses
maximum dose 1.5 mg/kg IV |
|
Dosing of SCh for intubation
|
0.6 mg/kg IV (range 0.3-1.1 mg/kg) over 10-30 seconds
|
|
these are the adverse effects of what drug: Muscle rigidity, Prolonged Myalgia, Raised intraocular pressure,Bradyarrhythmia, Tachyarrhythmia (especially in children),Hyperkalemia, Malignant hyperthermia, Hypersensitivity reaction
Rhabdomyolysis with myoglobinemia in children, Prolonged neuromuscular block, Respiratory depression, Apnea |
SCh
|
|
Mivacurium
|
Short-acting non-depolarizing
use with glaucoma pts OR setting <100/<60 hypotension |
|
Mivacurium ED 90-95 dose
|
0.07 (mg/kg)
|
|
Rhabdomyolysis is an adverse effect seen in children from this drug
|
SCh
|
|
initial dose of Mivacurium for intubation
|
0.15 mg/kg IV bolus over 5-15 sec OR 0.2 mg/kg IV bolus over 30 sec OR 0.25 mg/kg IV bolus in divided doses (0.15 mg/kg followed in 30 sec by 0.1 mg/kg)
|
|
when is Mivacurium used
|
used for glaucoma patients or in the OR setting
|
|
maintenance of Mivacurium
|
4 mcg/kg/min continuous IV infusion if initiated simultaneously with administration of initial dose
|
|
Adverse Effects of Mivacurium
|
Flushing, Bradyarrhythmia, Cardiac dysrhythmia, Hypotension(<100/<60), Tachyarrhythmia, Prolonged neuromuscular block
|
|
Rocuronium
|
Intermediate-Acting non-depolarizing
onset 2-3 min last 20-30 min |
|
What is Rocuronium used for
|
used for intubation of cerebral bleeds, hemorrhagic stroke pts
|
|
initial dosing of Rocuronium for induction of neuromuscular blockade
|
0.6 mg/kg IV
|
|
maintenance of Rocuronium for induction of neuromuscular blockade
|
0.1-0.2 mg/kg IV repeated as needed
|
|
Intubation initial dose for Rocuronium
|
initial, 0.6 mg/kg IV2) maintenance, 0.1-0.2 mg/kg IV repeated as needed
|
|
Rapid sequence intubation dose for Rocuronium
|
0.6 to 1.2 mg/kg IV
|
|
Rocuronium is also used for
|
for anesthetic procedure
|
|
Adverse Effects of Rocuronium
|
Injection site pain, Cardiac dysrhythmia (rare), Hypertension, Hypotension, Tachyarrhythmia (rare), Anaphylaxis (rare)
|
|
what is the onset and how long does Rocuronium last?
|
Onset 1 -2 minutes, last 25-30 minutes
|
|
Premedication for anesthetic procedure
|
0.05 to 0.06 mg/kg IV 1.5-3 min prior to succinylcholine administration
|
|
the prototypic blocker of the muscarinic receptor
|
atropine
|
|
some anti-choligernic agents
|
Atropine
Mushrooms (recreational drug) Benadryl tricyclic anti-depressants |
|
this drug is used for intubation in pts with cerebral bleeds
|
Rocuronium
|
|
Intubation drug choice if pt has arrythmias
|
Rocuronium because dysrythmias are rare
|
|
Safest intubation drug with liver and renal disease
|
Cisatracurium; it aslo has the least number of adverse effects;
metabolized by the bile and it doesn't accumulate used with hard intubations: HIV, Thrush, spinal surgeries, oral candidiasis, cancer |
|
don't use this drug with renal pts, CHF, cardiac problems
|
Atracurium because it causes edema, cardiac and many others adverse effects
|
|
Initial dose of Vecuronium
|
Initial: O.O8-0.1 mg/kg IV bolus
Maintenance: 0.010-0.015 25-40 min after initial dose |
|
drugs of choice for difficult intubation
|
Cisatracurium
Vecuronium |
|
Long-Acting Nondepolarizing NMBs
|
Pancuronium
Doxacurium 60-90 min |
|
This drug is not used for intubation
|
Pancuronium because it has a 3-5 min onset
|
|
Pancuronium facts
|
3-5 onset
DOA=60-90 min Do not use in hepatic failure or renal failur > risk of cardiac dysrhythmias |
|
Drug that gives you hyper salivation
|
Pancuronium
|
|
Intermediate acting drugs
|
Rocuronium
Atracurium Cistracurium Vecuronium 20-30 min |
|
Initial dose for Doxacurium
|
0.05 mg/kg IV
if used in combo with SCh, initial dose is half(0.025) |
|
what can prolong the paralytic effects of NMBs
|
Aminoglycosides(gentomycin,tobromycin)
antibiotics anaesthetic gases magnesium Digoxin(antiarythmic) |
|
what decreases the NMB effects
|
Hypercalcemia
Hyperkalemia phenytoin anticholinesterases carbamazepin |
|
short acting drugs
|
SCh
Mivacurium onset less than 1 minute |
|
When do you use NMBs
|
To allow intubation
Dangerous movements of pt Poor oxygenation despite adequate sedation |
|
what do you do before starting a paralytic
|
adequate sedation and analgesia
|
|
What is the train-of-four
|
a machine that test muscular twitches to monitor sedation; they should be at 1-2 twitches
|
|
Drugs that treat thromboembolism
|
Heparin
Lovenox Arixtra Coumadin |
|
Drug used to treat acute MI, ischemic stroke, and Heparin induced Thombocytopenia (TCP)
|
Argotraban
|
|
duration of heparin and lovenox
|
6-12 hrs, so when you send pt home, send them on coumadin to keep them anticouagulated
|
|
warfarin (coumading)
|
takes 3-5 days to work
start at 5 mg too much will give you purple toe syndrom(depletion of protein C and S) get INR/PT daily at first goal 2-3 INR then DC heparin |
|
Antiplatelets
|
ASA-inhibits COX 1
Plavix-inhibits ADP Persantine Aggrenox |
|
Cox 2 inhibitor
|
Celebrex
|
|
Cox 1 inhibitors
|
NSAIDs
ASA |
|
what part of the coagulation cascade does plavix work on?
|
inhibits ADP
|
|
ASA and Aggrenox work on what
|
inhibits thromboxine
|
|
how long do platelets live
|
about a week
|
|
if you're going to have surgery, when should you stop taking ASA and Plavix
|
1 week
|
|
loading dose for plavix in acute MI
|
300 mg
|
|
alternative med for aspirin, if pt is allergic
|
Plavix
|
|
Drug of choice for post-MI, ACS
|
Aspirin, can also be used in combo with plavix
|
|
what drug is used to treat malignant hyperthermia
|
dantrolline, given IV
|
|
example of an immediate release drug
|
Cardizam
|
|
macromolecular drug carriers
|
albumin
dextran DNA glucoproteins |
|
Epi binds to these receptors
|
a1 and B-adrenergic receptors of liver cells
|
|
the negative consequence of Epi
|
cardiac irritability, can lead to complications after ressucitation
|
|
effect of Epi on vessels of bronchioles
|
vasodilation
|